August 31, 2011. The New York Times. Dr. Diana Zuckerman, president of National Research Center for Women & Families, told an FDA advisory panel that Allergan and Mentor did a poor job studying patients that got silicone implants.
MSNBC. June 22, 2011. Diana Zuckerman, president of the National Research Center for Women & Families, says the studies the FDA used to say silicone implants are safe are incomplete. In addition, Zuckerman claims women need to understand that when they get breast implants they may need removal or replacements for the rest of their lives.
The Miami Herald. July 29, 2011. NRC President Diana Zuckerman expresses concern over the vast majority of medical devices being cleared through the 510(k) process—a process which has been described as “flawed” by Institute of Medicine panelists in a new report.
July 29, 2011. The prestigious Institute of Medicine (IOM) released a report on the Food and Drug Administration’s 510(k) medical device clearance process stating the system is “flawed” and should be revised. The report echoes the National Research Center for Women & Families’ concerns about the lack of evidence that these devises actually work and are safe.
Anemia drugs are widely used by patients undergoing chemotherapy and patients with chronic kidney disease, but there is growing evidence that the misuse of these drugs is harming many patients. The latest FDA “communication” again raises concerns about the safety of these drugs for any use, including patients with anemia due to chemotherapy. Studies show that cancer patients who receive ESAs have worse outcomes than patients who do not, because of higher mortality rates as well as faster cancer progression.